Clinical Trial Update: Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying whether L-Dopa (levodopa) may have a protective effect in retinitis pigmentosa. The study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• L-Dopa (Levodopa)

Snippet

Sponsor: Beirut Eye Specialist Hospital | Conditions: Retinitis Pigmentosa | Phase 2 | Status: UNKNOWN